JOSEPH PINCIOTTI: Open Payments
NPI 1265460539 · MORRISVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,074 in 151 payments from 25 companies in 2025. Trend: 2023 $120 · 2024 $2,504 · 2025 $3,074
Food & beverage: $3,074
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $570 |
| Otsuka America Pharmaceutical, Inc. | 15 | $301 |
| Novo Nordisk Inc | 16 | $299 |
| Sumitomo Pharma America, Inc. | 14 | $277 |
| Astellas Pharma US Inc | 10 | $275 |
| PFIZER INC. | 12 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $159 |
| Exact Sciences Corporation | 6 | $115 |
| Lundbeck LLC | 4 | $88 |
| ABBVIE INC. | 5 | $86 |
Products named: REXULTI, AIRSUPRA, GEMTESA, Veozah, FARXIGA, XIFAXAN, Wegovy, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
